Your personalized protocol

Recovery and Sleep Optimization Protocol

Given your high training volume and recovery bottleneck, this stack prioritizes tissue repair and HGH pulse enhancement during sleep. BPC-157 and TB-500 operate through complementary pathways, while the GH secretagogue pair amplifies the natural growth hormone pulse overnight.

84
Confidence
92
Recovery
78
Sleep
88
HGH support
4
Peptides in stack
Primary Moderate evidence
BPC-157
Synthetic peptide derived from gastric juice protein. Promotes angiogenesis, upregulates growth hormone receptors, and activates the nitric oxide system to accelerate tissue repair across musculoskeletal, tendon, and gut tissue.
Dosing
250–500 mcg daily
Timing
Split AM/PM, subcutaneous near injury site
Cycle
12 weeks on, 4 weeks off
Research notes

Extensive animal data showing accelerated tendon, muscle, and ligament healing. Human case reports align with animal findings. No RCTs yet published.

Contraindications
⚠ Active cancer (promotes angiogenesis)
⚠ Recent surgery with active bleeding risk
Synergy with
TB-500 GHK-Cu
Primary Moderate evidence
TB-500 (Thymosin Beta-4)
Naturally occurring peptide that sequesters G-actin, promotes cell migration and differentiation, and has systemic anti-inflammatory effects. Especially effective for cardiac muscle, tendons, and connective tissue.
Dosing
2–2.5 mg 2x/week loading, then 2 mg every 2 weeks
Timing
Subcutaneous, any time of day
Cycle
6 weeks loading, ongoing maintenance
Research notes

Phase II cardiac trial data supports safety. Animal studies show superior tendon and ligament repair vs. controls. Systemic distribution unlike BPC-157.

Contraindications
⚠ Active cancer or cancer history
⚠ Consult physician if history of autoimmune disease
Synergy with
BPC-157
Secondary Moderate evidence
Ipamorelin / CJC-1295
Ipamorelin is a selective GHRP that triggers a clean GH pulse without cortisol or prolactin elevation. CJC-1295 amplifies and extends the GH pulse as a GHRH analog. Combined, they produce a strong, sustained GH release during sleep.
Dosing
Ipamorelin 200 mcg + CJC-1295 100 mcg combined
Timing
30 min before sleep, empty stomach, no carbs 2 hrs prior
Cycle
5 days on, 2 days off. Re-evaluate at 12 weeks
Research notes

CJC-1295 clinical trials demonstrated sustained GH elevation. Ipamorelin's selectivity profile is well-documented. Stack combination widely used in clinical anti-aging practice.

Contraindications
⚠ Active cancer
⚠ Insulin resistance or uncontrolled diabetes
⚠ Acromegaly or elevated IGF-1
Synergy with
Epithalon DSIP
Optional Preliminary evidence
DSIP (Delta Sleep-Inducing Peptide)
Neuropeptide that promotes slow-wave sleep architecture and modulates stress responses via the HPA axis. Particularly effective for disrupted sleep patterns and training-related cortisol elevation.
Dosing
100–300 mcg
Timing
30–60 min before sleep, intranasal or subcutaneous
Cycle
3 weeks on, 1 week off
Research notes

Human studies from the 1980s showed sleep quality improvements. More limited modern data but clinical use is consistent with early findings.

Contraindications
⚠ Consult physician if on sleep medications or benzodiazepines
Synergy with
Ipamorelin / CJC-1295 Epithalon
Stack synergies

BPC-157 and TB-500 address tissue repair through distinct but complementary pathways — local vs. systemic, with additive effects in animal models. The GH secretagogue pair potentiates the repair effect by elevating IGF-1 overnight. DSIP deepens sleep architecture, extending the duration of the natural GH pulse window.

Full cycle protocol

Weeks 1–6: All four compounds at full dosing (loading phase for TB-500).
Weeks 7–12: BPC-157 continue daily, TB-500 move to maintenance every 2 weeks, continue GH stack and DSIP.
Weeks 13–16: Off all compounds.
Reintroduce based on recovery needs after the off period.

Individual schedules
BPC-157
Split AM/PM, subcutaneous
250–500 mcg/day 12 wks on / 4 off
TB-500
Any time of day, subcutaneous
2.5 mg 2x/wk loading 2 mg 2x/mo maint.
Ipamorelin / CJC-1295
30 min before sleep, empty stomach
200 mcg / 100 mcg 5 on / 2 off
DSIP
30–60 min before sleep
100–300 mcg 3 wks on / 1 off
Important considerations
• Source peptides only from reputable, third-party tested suppliers — quality control varies dramatically in the research peptide market.
• GH axis peptides (Ipamorelin/CJC-1295) should be cycled to prevent receptor desensitization.
• Monitor fasting IGF-1 levels before and during use if possible — this provides objective feedback on GH axis activation.
• Insulin sensitivity can be affected by chronic GH elevation. Be mindful if on any blood sugar management regimen.
• BPC-157 is currently Schedule 4 in Australia and unscheduled in most other jurisdictions — verify your local regulations.
Why this stack

Given your high training volume and recovery bottleneck, this stack prioritizes tissue repair and HGH pulse enhancement during sleep. BPC-157 and TB-500 operate through complementary pathways — BPC-157 is highly localized and systemic simultaneously, while TB-500 drives actin upregulation for broad tissue remodeling. Ipamorelin with CJC-1295 amplifies the natural GH pulse during deep sleep, compounding the recovery effect.

BPC-157 Moderate evidence

Promotes angiogenesis, upregulates growth hormone receptors, and activates the nitric oxide system to accelerate tissue repair across musculoskeletal, tendon, and gut tissue.

Extensive animal data showing accelerated tendon, muscle, and ligament healing. Human case reports align with animal findings. No RCTs yet published.

TB-500 (Thymosin Beta-4) Moderate evidence

Sequesters G-actin, promotes cell migration and differentiation, and has systemic anti-inflammatory effects. Especially effective for cardiac muscle, tendons, and connective tissue.

Phase II cardiac trial data supports safety. Animal studies show superior tendon and ligament repair vs. controls. Systemic distribution unlike BPC-157.

Ipamorelin / CJC-1295 Moderate evidence

Ipamorelin is a selective GHRP that triggers a clean GH pulse without cortisol or prolactin elevation. CJC-1295 amplifies and extends the pulse as a GHRH analog.

CJC-1295 clinical trials demonstrated sustained GH elevation. Ipamorelin's selectivity profile is well-documented. Stack combination widely used in clinical anti-aging practice.

DSIP Preliminary evidence

Neuropeptide that promotes slow-wave sleep architecture and modulates stress responses via the HPA axis.

Human studies from the 1980s showed sleep quality improvements. More limited modern data but clinical use is consistent with early findings.

ⓘ

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before beginning any peptide protocol, especially if you have underlying health conditions or take medications.

Protocol copied to clipboard